Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Medicenna Therapeutics Corp. (MDNAF) had Weighted-Average Shares Outstanding (Diluted) of 83.19M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-13.32M |
|
-- |
|
-- |
|
$16.23M |
|
$-16.23M |
|
$2.90M |
|
$-13.32M |
|
$-13.32M |
|
$-13.32M |
|
$-13.32M |
|
$-13.32M |
|
$-13.32M |
|
$-16.23M |
|
$-16.17M |
|
83.19M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
83.19M |
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$6.02M |
|
$0.00M |
|
$0.10M |
|
$6.12M |
|
$3.96M |
|
-- |
|
$0.37M |
|
$4.32M |
|
$1.80M |
|
$1.76M |
|
$1.80M |
|
83.42M |
|
| Cash Flow Statement Financials | |
$-12.97M |
|
$0.00M |
|
$-0.01M |
|
$17.98M |
|
$4.52M |
|
$-13.45M |
|
$1.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-741.70% |
|
-756.02% |
|
-217.75% |
|
-741.70% |
|
$0.02 |
|
$-0.16 |
|
$-0.16 |
|